Rasim Enar

Rasim Enar

Auto-generated profile, based on publicly available information

Rasim Enar

ISTANBUL UNIVERSITY-CERRAHPASA, CERRAHPAŞA SCHOOL OF MEDICINE, DEPARTMENT OF INTERNAL MEDICINE, DEPARTMENT OF CARDIOLOGY

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 June 2013 in Clinical Cardiology
Verified
Journal Article
Open access
PDF file
SOSevgi Ozcan
Sevgi Ozcan
HCHuseyin Altug Cakmak
Huseyin Altug Cakmak
BIBaris Ikitimur
Baris Ikitimur
EYEce Yurtseven
Ece Yurtseven
BSBerna Stavileci
Berna Stavileci
RERasim Enar
Rasim Enar
Background: Narrow fragmented QRS (fQRS) has recently been recognized as a significant predictor of prognosis in various cardiovascular diseases.Hypothesis: We hypothesized that the presence of narrow fQRS on admission electrocardiogram (ECG) in patients with decompensated systolic heart failure (HF) of any cause would be associated with long‐term prognosis.Methods: Patients hospitalized for decompensated HF due to ischemic or nonischemic dilated cardiomyopathy (left ventricular ejection fraction <35%) were retrospectively analyzed. The primary clinical end points were cardiovascular mortality, sudden cardiac death, and rehospitalization for HF.Results: The mean duration of follow‐up was 3.73 ± 1.41 years. Patients were classified as fQRS(+) group (n = 114; mean age, 63.49 ± 12.04 years) and fQRS(−) group (n = 113 patients; mean age, 65.04 ± 11.95 years). fQRS on ECG was significantly correlated with New York Heart Association (NYHA) functional class (P = 0.001). In multivariate Cox proportional hazard analysis, narrow fQRS (odds ratio [OR]: 3.130, 95% confidence interval [CI]: 1.560‐2.848, P = 0.001), chronic renal failure (OR: 2.455, 95% CI: 1.120‐5.381, P = 0.025), NYHA class (OR: 8.305, 95% CI: 2.568‐26.855, P < 0.0001), and hypoalbuminemia (OR: 2.099, 95% CI: 1.122‐3.926, P = 0.020) were independent predictors of cardiovascular mortality. In Kaplan‐Meier survival analysis, narrow fQRS on admission ECG predicted worse survival rate at 84 months; survival probability significantly decreased in the fQRS(+) group compared with fQRS(−) group (P < 0.0001).Conclusions: Presence of narrow fQRS is associated with worse NYHA functional class in patients hospitalized for decompensated HF. Narrow fQRS predicts cardiovascular mortality in a specific subgroup of systolic HF patients, namely those hospitalized for decompensated HF of both ischemic and nonischemic causes.

9 December 2019 in Istanbul Medical Journal
Verified
Journal Article
Closed access
TOTimor Omar
Timor Omar
RERasim Enar
Rasim Enar
BİBarış İkitimur
Barış İkitimur
BABurcak Kilickiran Avci
Burcak Kilickiran Avci

1 October 2022 in European Heart Journal
Verified
Journal Article
Open access
PDF file
DRD Raimoglou
D Raimoglou
MKM H Karpuz
M H Karpuz
RER Enar
R Enar
BKB Karadag
B Karadag
BIB Ikitimur
B Ikitimur
EDEser Durmaz
Eser Durmaz
Background: The adrenergic system plays a central role during the clinical course of hypertrophic cardiomyopathy (HCM) and hence beta-blocker therapy is the first-line treatment option according to current guidelines. Previous studies demonstrated variable cellular response to an adrenergic stimulus due to adrenoceptor-1 (ADRB-1) gene polymorphism in several patient groups including hypertension and dilated cardiomyopathy. Moreover, the impact of beta-blockers is also variable in these patients. Purpose: We aimed to investigate the impact of ADRB-1 gene polymorphism on structural and functional features among patients with HCM. Methods: In this study, we investigated the roles of Arginin389Glycine and Glycine49Serine polymorphism. Patients with a clear diagnosis of HCM according to current guidelines were included. Structural features including maximal wall thickness, interstitial fibrosis and left ventricular/atrial volumes were obtained using cardiac MRI and transthoracic echocardiography. Functional features including heart rate, blood pressure, left ventricular outflow obstruction were also recorded. The risk of sudden cardiac death was calculated using the HCM risk score. The impact of beta-blocker therapy on heart rate and blood pressure were also compared. Results: After the exclusion of patients, 147 patients were included in the study. 77% of the study population were male and the mean age was 49.5 years. The hypertrophic segment was septum in 83% of the study population. The mean maximum wall thickness was 20 mm (19–23). With respect to Ser49Gly polymorphism, Serine homozygotes demonstrated higher late-gadolinium enhancement and indicator of interstitial fibrosis (p: 0.007). In concordance with higher LGE, the presence of fragmented QRS on surface ECG (p: 0.026) and a higher prevalence of non-sustained ventricular tachycardia (p: 0.016) in these patients were observed. The risk of sudden cardiac death was also higher in Ser49 homozygotes (p: 0.041). However, with respect to Arg389Gly gene polymorphism, there was no significant difference between Arg389 homozygotes, Arg389Gly heterozygotes and Gly389 homozygotes in terms of structural and functional features. The vast majority of patients reported improved functional capacity and decreased shortness of breath during the follow-up regardless of ADRB-1 gene polymorphism which is objectively validated by decreased pro-BNP levels in all patients. Conclusion: Our results indicated that ADRB-1 gene polymorphism, particularly Ser49Gly gene polymorphism may have a significant role during the clinical course of HCM. Since Ser49 homozygote patients demonstrated higher interstitial fibrosis and a higher risk of sudden cardiac death, further studies are required to determine the significance of Ser49Gly gene polymorphism in HCM patients. Funding Acknowledgement: Type of funding sources: Public Institution(s). Main funding source(s): Bilimsel Arastırma Projesi (BAP) - Istanbul University - Cerrahpasa, Cerrahpasa Medical School

24 January 2026 in Anadolu Kliniği Tıp Bilimleri Dergisi
Verified
Journal Article
Open access
ODOmer Dogan
Omer Dogan
HBhasan ali barman
hasan ali barman
AEAbdullah Omer Ebeoğlu
Abdullah Omer Ebeoğlu
AAadem atici
adem atici
SESevval Ilke Ebeoglu
Sevval Ilke Ebeoglu
RERasim Enar
Rasim Enar
Aim: We aimed to identify predictors of mortality and re-admission for worsening heart failure (HF) in patients hospitalized for acute decompensated HF with reduced EF who survived until discharge. Methods: A total of 767 chronic HF patients with LVEF ≤ 0.40 who were admitted to the hospital for acute decompensation between 2009-2016 and survived until discharge after treatment were enrolled and followed for up to 5 years. The primary end points of the study included cardiovascular death after index hospitalization and re-admission to the hospital for worsening HF. Results: Primary end points of the study were reached in 40% of cases in the form of cardiovascular death and 71% of cases were re-hospitalized for worsening HF during 5-years follow-up after index hospitalization. After multivariate analysis in cox-regression analysis; NYHA (New York Heart Association) class (p